The Foundation for Prader-Willi Research logo

The Foundation for Prader-Willi Research

North America, California, United States, Walnut

Description

The Foundation for Prader-Willi Research is a nonprofit corporation with federal tax exempt status as a public charity.

Investor Profile

The Foundation for Prader-Willi Research has made 6 investments, with 1 in the past 12 months and 17% as lead.

Stage Focus

  • Series A (33%)
  • Series C (17%)
  • Convertible Note (17%)
  • Series B (17%)
  • Series Unknown (17%)

Country Focus

  • United States (67%)
  • Canada (17%)
  • Spain (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Foundation for Prader-Willi Research frequently co-invest with?

Vickers Venture Partners
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
SC
North America, Massachusetts, United States, Boston
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
SymBiosis
North America, Arkansas, United States, Bentonville
Co-Investments: 1
Laurion Capital Management
North America, New York, United States, New York
Co-Investments: 1
LG Technology Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Tetragon Financial Group Limited
North America, New York, United States, New York
Co-Investments: 1
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 1
CF
North America, Ontario, Canada, Toronto
Co-Investments: 1

What are some of recent deals done by The Foundation for Prader-Willi Research?

Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series CMay 9, 2024
Amount Raised: $85,000,000
PaloBiofarma

Barcelona, Catalonia, Spain

Innovation Through Medicinal Chemistry

BiotechnologyHealth Care
Convertible NoteMay 4, 2023
Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series BAug 5, 2021
Amount Raised: $29,000,000
Beryl Therapeutics

Longmont, Colorado, United States

Beryl is developing a patented first-in-class small molecule to increase peak bone mass and cure poor bone mineral density.

BiotechnologyHealth CareTherapeutics
Series UnknownJan 1, 2021
Lipidio Pharmaceuticals

San Diego, California, United States

Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.

BiopharmaBiotechnologyHealth CareMedical
Series AMar 3, 2020
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series AJul 25, 2018
Amount Raised: $7,000,000